Meluzio Michael Vincent
SEC insider (Form 3/4/5 filer). CIK 0002138368. VP, Prin. Accounting Officer at Cue Biopharma, Inc. (CUE). 6 reported Form 4/5 transactions since Sep 2024; latest on Oct 12, 2026. Located in SOMERVILLE, MA.
Companies Meluzio Michael Vincent has filed insider reports for
- Cue Biopharma, Inc. (CUE): Officer, VP, Prin. Accounting Officer
Meluzio Michael Vincent
CIK: 0002138368
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)4 (66.7%)
Position reduction
Option Exercises (M)1 (16.7%)
Derivative conversions
Awards (A)1 (16.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CUE
Cue Biopharma, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Oct 12, 2026CUE
Cue Biopharma, Inc.
SaleDirect1.1K shares at avg. $28.05$32K - Aug 13, 2026CUE
Cue Biopharma, Inc.
ExerciseDirect13.6K shares- - Aug 13, 2026CUE
Cue Biopharma, Inc.
SaleDirect1.5K shares at avg. $29.37$45K - Aug 13, 2026CUE
Cue Biopharma, Inc.
SaleDirect4.1K shares at avg. $30.35$125K - Aug 13, 2026CUE
Cue Biopharma, Inc.
SaleDirect3 shares at avg. $31.13$93.39 - Jul 9, 2026CUE
Cue Biopharma, Inc.
AwardDirect40.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 12, 2026 | CUE Cue Biopharma, Inc. | Sale | 1,144 | $28.05 | $32,089 | Direct |
| Aug 13, 2026 | CUE Cue Biopharma, Inc. | Exercise | 13,647 | - | $0 | Direct |
| Aug 13, 2026 | CUE Cue Biopharma, Inc. | Sale | 1,519 | $29.37 | $44,613 | Direct |
| Aug 13, 2026 | CUE Cue Biopharma, Inc. | Sale | 4,106 | $30.35 | $124,617 | Direct |
| Aug 13, 2026 | CUE Cue Biopharma, Inc. | Sale | 3 | $31.13 | $93 | Direct |
| Jul 9, 2026 | CUE Cue Biopharma, Inc. | Award | 40,942 | - | $0 | Direct |
1-6 of 6 transactions